I think that 12.5 seems to be a floor, and with such a small float, anyone
selling could drive the stock that low; I also doubt that it goes below 13.5
so the floor won't even be touched; They need to announce who their
customers are that are adapting the technology, both European, and American;
small stock, dangerous, could be bigger, but maybe not today;
I'll buy at 13, not 15.5; but then again, the mm's could push it back to 17;
I think dead money for a while; and it would be tough to exit in volume,
but easier to accumulate;
I would say bring it on. Push it down. Ha ha and I will buy. No worries with regards to rgen business model here. Have been with this one for quite some time now. Ready to add more if they really work this one down.
They are saying "missed estimates". So I am thinking it will remain in the $14 range. Any dip to 13 will be bought out pretty fast. I have 20K ready to flow in if gap arises today
Since you both are longs what I would suggest is that if for some reason they push this down to upper 13s jump in and grab some for a quick ride back to the 15s easily. Only if the push down is due to "unrealistic" short reasons. shorts use even the slightest misses (ignoring future prospects) to push value down but that is an opportunity for the longs. Anyways GLTA
Hello Monkey -
Smarter people than me have advised to take a profit BUT BUT remain stubborn and love the story with bioprocessing so at $20 will consider - personally feel great at anything over $15 after the large run up -
hope your ok with that but everyone bought in at different times.....also owned 4,000 shares of ALXN and sold at $17 now at $170 ha! Only see a few bucks down and whatever happens tomorrow believe the second half of the year will be more productive and profitable.
Wish you the very best.
THIS IS EXCITING.....SURPRISE.....NEWS......BEHIND PROJECTIONS FOR SALES.......GUIDANCE......ETC.....SO WE WAIT. Believe we may remain in $13-$15 range for a few months but then progress the second half on good news and improved sales rev's.